Related Experiment Video
Updated: Aug 4, 2026

Gene-environment Interaction Models to Unmask Susceptibility Mechanisms in Parkinson's Disease
Published on: January 7, 2014
Symposium introduction: retrospect and prospects for neuropathy target esterase (NTE) and the delayed polyneuropathy
1MRC Toxicology Unit, University of Leicester, UK.
Abstract:
This article introduces a Symposium devoted to Neuropathy Target Esterase (NTE). The characteristics of the disorder known as OPIDP are described and the steps by which NTE was identified as the target are summarised. Studies with many organophosphates, phosphinates and chiral phosphonates are entirely consistent with a 2-step process of initiation referred to as 'NTE (70-80%) aging': about 70-80% of available nervous system NTE is first covalently phosphylated causing inhibition of esterase activity, and then the molecules of inhibited NTE undergo a covalent bond-cleavage leaving a negative charge in the region of the still-bound phosphorus. This understanding has clarified structure/activity studies of neuropathic potential of OP esters and is now routinely applied in toxicological evaluations for regulatory purposes. However, the biological function of NTE has remained a mystery. Prospective views of the role of NTE are presented by different authors. Attempts to isolate catalytically active or radiolabelled inhibited NTE are near to success. Since the Symposium, complete isolation of NTE affinity-purified from hen brain has been reported (see M.K. Johnson & P. Glynn, Toxicologist, 13 (1993) 211, Abstr. 773). Some minor, but possibly significant, differences in properties of a soluble and a membrane-bound form of NTE in sciatic nerve has been identified. The nature of the disturbance brought about by covalent binding of organophosphoramidates at the active site of NTE and the discovery that 'non-aging' inhibitors of NTE can promote neuropathy in hens given a sub-neuropathic dose of neuropathic OPs has led to a concept of NTE inhibitors having a range of 'partial agonist' effects at the covalent binding site. Evidence is emerging that the promotion target may be 'cousin-of NTE' with very similar inhibition characteristics and a function in the processes of response to or repair of axonal damage.
Insights
Neuropathy Target Esterase (NTE) is identified as the target of organophosphate-induced delayed neuropathy (OPIDP). Research clarifies the two-step aging process of NTE inhibition, aiding toxicological evaluations, though its biological function remains under investigation.
Area of Science:
- Neurotoxicology
- Biochemistry
- Enzymology
Background:
- Organophosphate-induced delayed neuropathy (OPIDP) is a neurotoxic disorder.
- Neuropathy Target Esterase (NTE) was identified as the molecular target of OPIDP.
- The precise biological function of NTE has remained elusive.
Purpose of the Study:
- To introduce a symposium focused on Neuropathy Target Esterase (NTE).
- To summarize the identification of NTE as the target of OPIDP.
- To discuss the current understanding and future directions regarding NTE's function and inhibition.
Main Methods:
- Review of studies involving organophosphates, phosphinates, and phosphonates.
- Characterization of the two-step 'NTE aging' process.
- Analysis of structure-activity relationships for neuropathic potential.
Main Results:
- A two-step mechanism ('NTE aging') involving phosphylation and subsequent bond cleavage explains NTE inhibition.
- This mechanism is crucial for understanding OP ester neuropathic potential and is used in regulatory toxicology.
- Evidence suggests NTE inhibitors may act as partial agonists, and a related enzyme ('cousin-of NTE') may be involved in axonal damage response or repair.
Conclusions:
- The 'NTE aging' model provides a framework for understanding OP-induced neurotoxicity.
- While NTE's function is still unknown, research is progressing towards its isolation and functional characterization.
- Emerging evidence points to a broader role for NTE and related enzymes in neuronal health and damage repair.
More Related Videos
07:30A Simple Approach to Induce Experimental Autoimmune Neuritis in C57BL/6 Mice for Functional and Neuropathological Assessments
Published on: November 9, 2017
09:39Establishing a Mouse Model of a Pure Small Fiber Neuropathy with the Ultrapotent Agonist of Transient Receptor Potential Vanilloid Type 1
Published on: February 13, 2018
Related Concept Videos
Anticholinesterase Agents: Poisoning and Treatment
Irreversible agents form a strong bond with the cholinesterase enzyme, making it inactive. The breakdown of the phosphorylated enzyme is slower than the...
Diabetic Neuropathy